Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- T-Cell Depleted Double UCB for Refractory AML: Complete Statistical AnalysisIndependent statistical analysis of T-Cell Depleted Double UCB for Refractory AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01464359).
- T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases: Complete Statistical AnalysisIndependent statistical analysis of T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases: primary endpoint results, effect estimate with confidence interval,…
- T-DEFIndependent statistical analysis of Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04206371).
- T-DM1Independent statistical analysis of T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03530696).
- T-GENVIH-003 LTFU (Long Term Follow Up) Study: Complete Statistical AnalysisIndependent statistical analysis of T-GENVIH-003 LTFU (Long Term Follow Up) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06034652).
- T1DoingWellIndependent statistical analysis of Strengths-Based Behavioral mHealth App for Parents of Adolescents With Type 1 Diabetes-Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- T1GERIndependent statistical analysis of A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00939653).
- t2pIndependent statistical analysis of txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- T3PAHIndependent statistical analysis of Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528902).
- TACACIndependent statistical analysis of Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206518).
- TACEIndependent statistical analysis of Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00539253).
- TACKLEIndependent statistical analysis of Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: primary endpoint results,…
- Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01680861).
- TACTIndependent statistical analysis of A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TACTIC AFIndependent statistical analysis of Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TAILOR-PCIIndependent statistical analysis of Tailored Antiplatelet Therapy Following PCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742117).
- Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Tailored Health Self-Management Interventions for Highly Distressed Family Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03023332).
- TAKE-ITIndependent statistical analysis of Intervention to Improve Adherence in Teen Kidney Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01356277).
- Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- TALCIndependent statistical analysis of Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC):…
- TALENTIndependent statistical analysis of An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TALONIndependent statistical analysis of Rapid Sternal Closure System (TALON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00638014).
- TAMBEIndependent statistical analysis of Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TAMEIndependent statistical analysis of Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00295646).
- Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions: Complete Statistical AnalysisIndependent statistical analysis of Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01149733).
- TANDEMIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis: primary endpoint results, effect estimate with…
- Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment: Complete Statistical AnalysisIndependent statistical analysis of Tandem Auto Transplantation in Myeloma Patients With
- Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Tanglewood Trail Walking Program in Rural Kentucky 2020: Complete Statistical AnalysisIndependent statistical analysis of Tanglewood Trail Walking Program in Rural Kentucky 2020: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05002985).
- TANGOIndependent statistical analysis of A Phase 3 Study of Tanezumab for Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TANGOIndependent statistical analysis of CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TAOATIndependent statistical analysis of Temporary Aortic Occlusion With the Abdominal Tourniquet for Refractory Postpartum Haemorrhage: A Proof-of-Concept Study in a War-Affected Region: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TAPIndependent statistical analysis of Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TAPIndependent statistical analysis of Trial Comparing Transversus Abdominis Plane Block Versus Epidural Anesthesia for Pain Management in Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TAP-PIndependent statistical analysis of Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TAPASIndependent statistical analysis of TissuePAtchDS--P ™ PArotidectomy Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04116762).
- Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002): Complete Statistical AnalysisIndependent statistical analysis of Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03983980).
- TAPPASIndependent statistical analysis of Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…